Light-activated drugs against neuropathic pain

by IBEC - Institut de Bioenginyeria de Catalunya

It has been developed light-activated derivatives of the anti-epileptic drug carbamazepine to treat neuropathic pain. These compounds, which show analgesic effects when activated by light, can inhibit...

Read more

AGC Pharma Chemicals y AbilityPharma trabajan juntos en la producción de un tratamiento innovador para el cáncer de páncreas

by AbilityPharma

Con este acuerdo, la biofarmacéutica española AbilityPharma inicia la fabricación de su fármaco principal ABTL0812 para administrar a pacientes con cáncer de páncreas en el marco del ensayo clí...

Read more

What is Open Innovation in pharmaceutical R&D?

by GENESIS Biomed

The core idea of Open innovation is that companies leverage the ideas and resources of external actors such as customers, suppliers, universities, start-ups, etc.

Read more

Luz verde al CAR-T ARI0002h desarrollado por el Clínic-IDIBAPS para pacientes con mieloma múltiple

by Fundació Clínic per a la Recerca Biomèdica

El Comité de Evaluación de Medicamentos de uso humano de la Agencia Española del Medicamento y Productos Sanitarios (AEMPS) ha dado el visto bueno al ARI0002h para su aprobación como medicamento d...

Read more

Strategic Alliances: Partnering for Success in the Global Pharma Market

by Rubió

Strategic alliances are crucial for success in the global pharma market. By forming partnerships, companies can access complementary capabilities, share risks, enhance market access, and leverage shar...

Read more

Development of a new pediatric treatment for insomnia

by Rubió

Products & Technology, a Rubió Group company, has undertaken research and development (R&D) to create a medication aimed at treating insomnia in children with Attention Deficit Hyperactivity Disorder...

Read more

Oxolife, participada por Inveready, desarrolla una píldora para la infertilidad, recibe el premio a la mejor comunicación científica

by Inveready

OXO-001 es un fármaco no hormonal, el primero en su clase, que actúa directamente sobre el endometrio (el revestimiento interno del útero) para hacerlo más propicio para la implantación del embri...

Read more

Cytoki Pharma Announces Positive Phase 1 Data Showing Potential of CK-0045 to Improve Cardiometabolic Risk Factors

by Ysios Capital

CK-0045 induced exposure-dependent reductions in body weight and improvement of key metabolic parameters in participants with obesity

Read more

Approved by EMA, novel oral AKT inhibitor in combination improves clinical outcomes and prolongs quality of life in patients with advanced HR+/HER2- breast cancer

by VHIO

The European Medicines Agency (EMA) recently approved the combination of novel AKT inhibitor capivasertib with fulvestrant for patients with hormone receptor (HR)-positive, HER2-negative advanced or m...

Read more

AbilityPharma anuncia la aprobación en China de un estudio clínico en cáncer pancreático con ABTL0812

by AbilityPharma
  • 8 years ago

AbilityPharma (Ability Pharmaceuticals, S.L.), una compañía biofarmacéutica catalana especializada en el desarrollo de fármacos oncológicos, ha anunciado hoy que su socio en China, SciClone (SciC...

Read more

AbilityPharma receives WHO approval for its ABTL0812 anticancer drug to be named IBRILATAZAR

by AbilityPharma

AbilityPharma announces that the World Health Organization (WHO) has recommended ABTL0812, a first-in-class oral drug for cancer treatment that causes selective death of cancer cells through autophagy...

Read more

ORYZON to provide corporate progress updates at several events in September

by Oryzon Genomics

Oryzon Genomics announced today that its management will give an update on corporate progress at several international events in September.

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Telum Therapeutics Secures €18 Million...

by Telum Therapeutics

Telum Therapeutics, a biotechnology company leveraging proprietary met...

Photos Stream